Haemophilic arthropathy: Diagnosis, management, and aging patient considerations
Authors:
- 5 April 2024
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 30 (S3) , 120-127
Abstract
Gene therapy and universal use of safer, more effective, and personalised prophylactic regimens (factor, and nonfactor) are expected to prevent joint bleeding and promote joint health in persons with haemophilia (PwH). Growing evidence suggests that subclinical bleeding, with active and inactive synovial proliferation, continues and haemophilic arthropathy remains a major morbidity in PwH despite early institution of joint prophylaxis. Joint health assessment is evolving with physical examination scores complementing imaging scores. Point‐of‐care ultrasound is emerging as a safe, cost‐effective, and readily available tool for acute determination of musculoskeletal abnormalities, serial evaluation of joints for sonographic markers of haemophilic arthropathy, and in providing objective insight into the efficacy of new therapies. In acute haemarthrosis, arthrocentesis expedites recovery and prevent the vicious cycle of bleed‐synovitis‐rebleed. When synovial proliferation develops, a multidisciplinary team approach is critical with haematology, orthopaedics, and physiotherapy involvement. Synovectomy is considered for patients with chronic synovitis that fail conservative management. Non‐surgical and minimally invasive procedures should always be offered and considered first. Careful patient selection, screening and early intervention increase the success of these interventions in reducing bleeding, pain, and improving joint function and quality of life. Chemical synovectomy is practical in developing countries, but radioactive synovectomy appears to be more effective. When surgical synovectomy is considered, arthroscopic/minimally invasive approach should be attempted first. In advanced haemophilic arthropathy, joint replacement and arthrodesis can be considered. While excited about the future of haemophilia management, navigating musculoskeletal challenges in the aging haemophilia population is equally important.Keywords
This publication has 71 references indexed in Scilit:
- Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trialJournal of Thrombosis and Haemostasis, 2023
- Outcome of Joint Aspiration in Acute Knee Haemarthrosis in a Haemophilic Joint: A Prospective Randomised Controlled Trial in 120 Patients in a Tertiary Haemophilia Care CentreIndian Journal of Orthopaedics, 2022
- The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international studyResearch and Practice in Thrombosis and Haemostasis, 2022
- Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and cliniciansBlood Reviews, 2022
- Biochemical marker research in hemophilic arthropathy: A systematic reviewBlood Reviews, 2021
- Development and Reliability of the Joint Tissue Activity and Damage Examination for Quantitation of Structural Abnormalities by Musculoskeletal Ultrasound in Hemophilic JointsJournal of Ultrasound in Medicine, 2018
- Advanced Hemophilic Arthropathy: Sensitivity of Soft Tissue Discrimination With Musculoskeletal UltrasoundJournal of Ultrasound in Medicine, 2018
- Radiosynovectomy in haemophilia: Long-term results of 500 procedures performed in a 38-year periodThrombosis Research, 2014
- Radionuclide Synovectomy (Radiosynoviorthesis) in Hemophilia: A Very Efficient and Single ProcedureSeminars in Thrombosis and Hemostasis, 2003
- Synovectomy with rifampicine in haemophilic haemarthrosisHaemophilia, 2000